Conquering Diseases

Study Of An Investigational Drug For Metastatic Prostate Cancer That Is Resistant To Hormone Treatment


Seeking men whose prostate cancer has spread beyond their prostate despite treatment with androgen deprivation therapy (also known as castration resistant prostate cancer) for a study comparing the usual treatment to the usual treatment with an experimental drug on controlling the cancer.


We are studying whether adding an investigational drug to the usual treatment helps control prostate cancer. Some volunteers for this trial will be randomly assigned to get the investigational drug and others will get a drug that looks like the investigational drug, but contains no active medicine (placebo).

What we're hoping for

We hope that adding the investigational drug will help control prostate cancer.

Additional Information Identifier: NCT03834493

 Principal Investigator

Kriti  Mittal, MD, MS

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655